Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance

Mammary carcinoma is the most common malignant tumor in women, and it is the leading cause of mortality, with an incidence of ≥1,000,000 cases occurring worldwide annually. It is one of the most common human neoplasms, accounting for approximately one-quarter of all cancers in females worldwide and 27% of cancers in developed countries with a Western lifestyle. They exhibit a wide scope of morphological features, different immunohistochemical profiles, and unique histopathological subtypes that have specific clinical course and outcome. Breast cancers can be classified into distinct subgroups based on similarities in the gene expression profiles and molecular classification.

[1]  J. Peterse,et al.  Squamous Cell Carcinoma In Situ of the Breast: A Light Microscopic and Immunohistochemical Study of a Previously Undescribed Lesion , 2007, The American journal of surgical pathology.

[2]  J. Reis-Filho,et al.  Microarray-based Gene Expression Profiling as a Clinical Tool for Breast Cancer Management: Are We There Yet? , 2009, International journal of surgical pathology.

[3]  D'Arcy Pwer.  Some morphological changes occurring in epithelial cells as a result of disease , 1897 .

[4]  S. Schnitt,et al.  Lobular carcinoma in situ: current concepts and controversies. , 1999, Seminars in diagnostic pathology.

[5]  D. Visscher,et al.  Clinicopathologic Analysis of Invasive Micropapillary Differentiation in Breast Carcinoma , 2001, Modern Pathology.

[6]  J. Coyne.  DCIS and LCIS with multinucleated giant cells—a report of 4 cases , 2007, Histopathology.

[7]  F. Moinfar.  Essentials of Diagnostic Breast Pathology: A Practical Approach , 2007 .

[8]  S. Devries,et al.  Genetic and Phenotypic Characteristics of Pleomorphic Lobular Carcinoma In Situ of the Breast , 2009, The American journal of surgical pathology.

[9]  D. Page,et al.  Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. , 2001, Human pathology.

[10]  Umed A. Ajani,et al.  The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004 , 2009, Cancer Epidemiology Biomarkers & Prevention.

[11]  I. Bièche,et al.  Genetic pathways in the evolution of breast ductal carcinoma in situ , 2002, The Journal of pathology.

[12]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[13]  Ayesha Ahmed,et al.  Molecular classification of breast cancer: An overview with emphasis on ethnic variations and future perspectives , 2013 .

[14]  A. Hanby,et al.  In situ and invasive lobular neoplasia of the breast , 2007, Histopathology.

[15]  Teresa L. Mastracci,et al.  E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast , 2005, Modern Pathology.

[16]  K. Siziopikou,et al.  Rosen's Breast Pathology , 2009 .

[17]  R. Hoda,et al.  Rosai and Ackerman???s Surgical Pathology , 2004 .

[18]  N. Niles.  Pathologic Basis of Disease , 1974 .

[19]  D. Venter,et al.  The pathology of inherited breast cancer , 2002, Pathology.

[20]  G. Hortobagyi,et al.  Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Sunil R. Lakhani,et al.  WHO classification of tumours of the breast , 2012 .

[22]  D. John,et al.  Expression Distribution of Cancer Stem Cells, Epithelial to Mesenchymal Transition, and Telomerase Activity in Breast Cancer and Their Association with Clinicopathologic Characteristics , 2015, Clinical medicine insights. Pathology.

[23]  S. Schnitt.  Will Molecular Classification Replace Traditional Breast Pathology? , 2010, International journal of surgical pathology.

[24]  K. Gelmon,et al.  Breast carcinoma--rare types: review of the literature. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  Peter Devilee,et al.  Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .

[26]  Mbbs Md FRCPath Donald N. Pritzker Vinay Kumar.  Robbins and Cotran pathologic basis of disease , 2015 .

[27]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[28]  C. Mies,et al.  Application of immunohistochemistry to breast lesions. , 2008, Archives of pathology & laboratory medicine.